CORALVILLE, Iowa, Feb. 22, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK) announced that it has developed a new method of cryopreservation of human stem cells. This new method takes advantage of the superior thermal conductivity of Vivakor's VivaThermic vials and reduces the overall cryopreservation and thawing recovery times. Select leading stem cell researchers and institutions have begun testing this new method. To accommodate the response to this major advancement in cryopreservation, additional researchers and institutions interested in testing this new method of preservation are invited to contact Vivakor directly to determine if they qualify for participation in the Company's suitability studies utilizing the new VivaThermic 2.0 cryovials.
